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Key points 
• a total of 137/152 Local Authorities (LAs) returned vaccine coverage data for
the Td/IPV vaccination programme for Year 9 students (born between
1 September 2003 to 31 August 2004). Of these, 123 LAs delivered the
programme in schools, 12 LAs delivered the programme in schools and GP
practices, and two areas delivered the programme through GP practices
• average vaccine coverage for the LAs that delivered the Td/IPV booster to Year
9 students in 2017/18 was 85.5%, compared to 83.0% in 2016/17 and 83.5% in
2015/16
• a total of 150/152 LAs returned vaccine coverage data for Td/IPV vaccination
for Year 10 students in 2017/18 (born between 1 September 2002 to 31 August
2003). Of these, 136 LAs delivered the programme in schools, eight delivered
the programme in schools and GP practices, and six through GP practices
• 27 LAs that did not provide Year 9 data in 2016/17 provided Year 10 data in
2017/18
• Year 10 data for 42 LAs was calculated using the 2016/17 Year 9 denominator
and an updated numerator; for 30 LAs the 2016/17 Year 9 data was carried
over to 2017/18 unchanged
• average Year 10 coverage for the Td/IPV booster vaccine up to the end of
August 2018 was 82.9% compared to 81.7% in 2016/17 and 74.9% in 2015/16
• providers are encouraged to continue to move towards standardising on the
recommended Year 9 school delivery model in order to achieve high vaccine
coverage
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Introduction 
Tetanus, diphtheria and polio vaccines are offered at eight weeks, 12 weeks, 16 weeks 
(primary course), a pre-school booster at three years and four months, and a school 
leaver booster at 14 years old [1]. The school leaver booster is the fifth dose of tetanus, 
diphtheria and polio (Td/IPV) vaccine in the routine immunisation schedule and 
completes the course, providing long-term protection against all three diseases [1-4]. 
Any missed doses of diphtheria, tetanus and polio vaccines can be caught up at any 
age observing the appropriate intervals between doses as detailed in The Green Book.    
 
Previously annual Health and Social Care Information Centre (HSCIC, now NHS Digital) 
KC50 collections from primary care trusts (PCTs) had included number of doses of 
Td/IPV administered but did not contain reliable denominator data for all PCTs and so 
were unable to produce coverage estimates. The KC50 returns were suspended in 
2012/13 [5]. In 2015/16 and 2016/17 a pilot study collected national vaccine coverage 
data for the Td/IPV schools based immunisation programme [6] . This data collection 
has continued in 2017/18 for students in Years 9 and 10 across England [7].  
 
This report is the third vaccine coverage report for the Td/IPV schools based 
immunisation programme in England and presents updated data for school year 10 and 
new data for school year 9 in 2017/18.  
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Methods 
Data were collected at school level, aggregated by Local Authority (LA) and, where 
possible, updated with additional data for adolescents resident in the LA but not linked 
to any school. The aggregate LA data were manually entered on the ImmForm*  
website.  
The target population for the programme is defined by school age cohorts born between 
1 September 2002 and 31 August 2004. This also includes adolescents resident in the 
LA that are not linked to any school (Table 1). The numerator is defined by the number 
of adolescents in each cohort who had received a dose of Td/IPV vaccine by 31 August 
2018.  
Table 1. Td/IPV routine vaccine cohorts 2017/18 
School year in 2017/18 Age in 2017/18 Dates of birth 
10 14-15 years old 1 Sep 2002 – 21 Aug 2003 
9 13-14 years old 1 Sept 2003 – 31 Aug 2004 
Full details of the data collection process and definitions can be found in the user guide 
Adolescent Vaccine Coverage Collection (HPV and MenACWY & Td/IPV) 2017/18 
Local Authority Annual Survey Reference guide for NHS England local teams submitting 
annual vaccine coverage data on ImmForm.  
Participation and data quality 
Caveats describing participation and data quality issues are included within the data 
tables associated with this report.  
LA level data were validated and analysed by PHE to check data completeness and 
identify and query any anomalous results. The data were aggregated by NHS Local 
Team (LT) and at the national level. Vaccine coverage only represents the percent 
vaccinated with Td/IPV in LAs that delivered the programme and denominators for 
areas that did not provide data are not included in the survey calculations.  
* ImmForm is the system used by Public Health England to record vaccine coverage data for some immunisation
programmes and to provide vaccine ordering facilities for NHS England.
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Results 
Year 9 vaccine coverage 
• 137/152 (90.1%) LAs offered the routine Td/IPV vaccination in Year 9 in 2017/18
(123 in schools, 12 in schools and GP practices, and two in GP practices only)
• Td/IPV coverage in Year 9 in 2017/18 in those 137 LAs was 85.5%.This figure
excludes LAs that were unable to provide reliable data
• the 15 LAs not offering the routine vaccination to Year 9 in 2017/18 will offer it to
Year 10 students in 2018/19
• coverage ranged from 39.6% (Isle of Wight LA) to 97.0% (Wokingham LA).  A total
of 34/ 137 (24.8%) of LAs achieved coverage less than 80%, 68/137 (49.6%) LAs
achieving between 80 – 90%, and 35/137 (25.5%) achieved coverage of 90% or
above
• for the Year 9 estimates, denominator size increased by >10% in 15 LAs in 2017/18
compared with 2016/17. These increases are to the result of more accurate and
comprehensive school lists being available
Year 10 vaccine coverage 
• 150/152 (98.7%) LAs reported coverage for Td/IPV in Year 10 (combined Year 9
2016/17 and Year 10 2017/18 data) in 2017/18 (136 in schools, six in GP practices,
eight in schools and GP practices)
• Td/IPV coverage in Year 10 in 2017/18 in those LAs was 82.9%. This figure
excludes LAs with GP/mixed programmes that were unable to provide reliable data.
These LAs were also unable to provide reliable Year 9 data in 2016/17
• coverage ranged from 29.6% (Bristol LA) to 100.0% (Isles of Scilly LA). A total of
56/150 (37.3%) of LAs achieved coverage less than 80%, 60/150 (40.0%) LAs
achieving between 80 – 90%, and 34/150 (22.7%) achieved coverage of 90% or
above
• for the Year 10 estimates, denominator size increased by >10% in nine LAs in
2017/18 compared with 2016/17. These increases are to the result of more accurate
and comprehensive school lists being available
• 42 LAs carried over the 2016/17 Year 9 denominator and updated the numerator
• for 30 LAs the 2016/17 Year 9 data was carried over to Year 10 2017/18 unchanged
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Discussion 
Average vaccine coverage for the 2017/18 Year 9 school delivered programme was 
85.5% compared to 83.0% in 2016/17. This estimate should be regarded as provisional 
as the cohort will be evaluated again at the end of the academic year 2018/19 (Year 10) 
to provide more complete data. During 2017/18 the participation rate increased for the 
Year 10 cohort to 98.7% (150/152) LAs. Only two LAs, one offering a GP-only delivered 
programme and one LA offering a mixed school and GP delivered programme, were 
unable to make a return.   
 
For the majority of students this will be the fifth and final dose of Td/IPV vaccine. 
However, it is possible that vaccine coverage is overestimated as some students might 
have missed one of the initial four doses and may only be receiving a fourth dose of 
these vaccine antigens. Any missed doses of diphtheria, tetanus and polio vaccines can 
be caught up at any age observing the appropriate intervals between doses as detailed 
in The Green Book.    
 
Vaccine coverage of the Td/IPV booster in England is similar to coverage in Scotland, 
Wales and Northern Ireland (see table of UK data associated with this report). Please 
note that the denominator in Scotland, Wales and Northern Ireland represent the entire 
population for each age cohort, whereas the figures in England represent only the areas 
that successfully submitted reliable data on ImmForm. The figures presented in this 
report likely overestimate coverage nationally because they exclude missed cohorts and 
areas that have mixed models and were unable to provide accurate GP level data, 
which likely have lower coverage. However, the number of areas unable to provide 
accurate estimates in the report is small and will have a small impact on vaccine 
coverage. 
 
It is not possible for many LAs that offer a predominately school-delivered programme 
to include data on Td/IPV vaccine received in general practice. Consequently some 
areas presented data that includes vaccinations given in both schools and GP settings 
while other areas have only presented data that includes school-delivered vaccinations. 
This would result in an underestimation in vaccine coverage therefore compensating for 
the known overestimation due to missed cohorts not being included in the analyses.  
 
Achieving high coverage in older adolescents is a challenge. As with other adolescent 
vaccination programmes delivered through schools in England, the highest coverage is 
achieved in the younger cohorts [8]. It is possible that more comprehensive and 
complete data collection will help increase coverage in both Year 9 and Year 10 
students. Td/IPV vaccine coverage reported for Year 9 and 10 is similar to MenACWY 
vaccine coverage reported for the same schools years (Year 10 84.6%, Year 9 
86.2%) [8].  
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It is encouraging that since 2016/17 11 LAs have moved to offering the routine school 
leaver booster in Year 9 in 2017/18 and further areas have indicated that they will do so 
in the next year, enabling the programme to gradually move to the recommended Year 
9 delivery of Td/IPV nationally.  
Collecting accurate data for this vaccine programme is challenging, particularly when 
attempting to provide follow-up estimates for cohorts over more than one academic year 
and when there are multiple delivery models. Many areas that commission the 
programme in Year 9 carried over the denominator for Year 10 in 2017/18 and added 
any additional vaccines administered to the numerator. This could potentially 
overestimate vaccine coverage. Additionally, 30 LAs were unable to update the data 
submitted last year and carried over the 2016/17 Year 9 denominator and numerator 
which could in underestimate coverage if any additional students were vaccinated in 
2017/18. 
This survey will be repeated in September 2019 to collect coverage data for Td/IV 
vaccine delivered to Year 9 and 10 students in 2018/19.  
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